September 21, 2014 4:42 AM ET

Healthcare Providers and Services

Company Overview of Quest Diagnostics Inc.

Company Overview

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. It offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights; laboratory testing services for new drugs, vaccines, and medical devices; and risk assessment services for the life insurance industry. The company also develops, manufactures, and markets diagnostic products, including Simplexa molecular chemistries for testing infectious disease and ...

3 Giralda Farms

Madison, NJ 07940

United States

Founded in 1967

41,000 Employees

Phone:

973-520-2700

Key Executives for Quest Diagnostics Inc.

Chief Executive Officer
Age: 57
Total Annual Compensation: $1.1M
Chief Financial Officer and Senior Vice President
Age: 52
Total Annual Compensation: $472.1K
Chief Medical Officer and Senior Vice President of Hospital Services
Age: 59
Total Annual Compensation: $573.9K
Senior Vice President of Clinical Franchises
Age: 51
Total Annual Compensation: $520.0K
Senior Vice President and General Counsel
Age: 52
Total Annual Compensation: $492.1K
Compensation as of Fiscal Year 2013.

Quest Diagnostics Inc. Key Developments

Quest Diagnostics Inc. Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-08-2014 10:30 AM

Quest Diagnostics Inc. Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-08-2014 10:30 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Stephen H. Rusckowski, Chief Executive Officer, President, Director and Member of Executive Committee.

Quest Diagnostics Inc. Declares Quarterly Cash Dividend Payable on October 22, 2014

Quest Diagnostics announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share, payable on October 22, 2014 to shareholders of record of Quest Diagnostics common stock on October 7, 2014.

Quest Diagnostics Incorporated Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Reaffirms Earnings Guidance for the Year 2014

Quest Diagnostics Incorporated reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net revenues of $1,902 million compared to net revenues of $1,815 million for the same period a year ago. Operating income was $262 million compared to $289 million last year. Income from continuing operations before taxes was $229 million compared to $256 million last year. Income from continuing operations was $142 million compared to $161 million last year. Net income was $142 million compared to $174 million last year. Net income attributable to the company was $133 million compared to $165 million last year. Net income amounts attributable to the company common stockholders from income from continuing operations were $133 million or $0.92 per basic and diluted share compared to $152 million or $0.99 per basic and diluted share last year. Net income amounts attributable to the company common stockholders were $133 million or $0.92 per basic and diluted share compared to $165 million or $1.07 per basic and diluted share last year. Capital expenditures were $49 million in the second quarter of 2014. Adjusted operating income from continuing operations was $296 million, or 15.5% of revenues, compared to $308 million, or 16.9% of revenues, for 2013. Cash provided by operations was $280 million, compared to $208 million in the second quarter of 2013. Adjusted income from continuing operations was $157 million, or $1.08 per diluted share, compared to $164 million, or $1.06 per diluted share, for 2013. For the six months, the company reported net revenues of $3,648 million compared to net revenues of $3,602 million for the same period a year ago. Operating income was $470 million compared to $516 million last year. Income from continuing operations before taxes was $405 million compared to $453 million last year. Income from continuing operations was $253 million compared to $285 million last year. Net income was $253 million compared to $318 million last year. Net income attributable to the company was $237 million compared to $301 million last year. Net income amounts attributable to the company common stockholders from income from continuing operations were $237 million or $1.63 per diluted share compared to $268 million or $1.71 per diluted share last year. Net income amounts attributable to the company common stockholders were $237 million or $1.63 per diluted share compared to $301 million or $1.92 per diluted share last year. Net cash provided by operating activities was $364 million compared to $255 million last year. Capital expenditures were $117 million compared to $105 million last year. Adjusted income from continuing operations was $279 million, or $1.92 per diluted share, compared to $307 million, or $1.95 per diluted share, in 2013. Adjusted operating income from continuing operations for the first half of 2014 was $532 million, or 14.6% of revenues, compared to $579 million, or 16.1% of revenues, for 2013. For the year 2014, the company estimates results from continuing operations, before special items, as follows: Revenues expected to increase 2.5% to 3.5% compared to the prior year, versus previous guidance of up 2% to 4%; Adjusted diluted EPS to be between $4.00 and $4.10, versus previous guidance of between $3.95 and $4.15; Cash provided by operations to approximate $900 million, unchanged; and capital expenditures to approximate $300 million, unchanged.

Similar Private Companies By Industry

Company Name Region
The CORE Institute United States
Center For Emergency Medicine Of Western Pennsylvania, Inc. United States
Munson Healthcare, Inc. United States
Metroplex Adventist Hospital, Inc. United States
Lexington Memorial Hospital, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
April 23, 2014
Steward Health Care System, LLC, Laboratory Service Operations
Merger/Acquisition
March 11, 2014
Summit Health, Inc.
Merger/Acquisition
January 22, 2014
Solstas Lab Partners Group, LLC
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Quest Diagnostics Inc., please visit www.questdiagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.